| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vice Chairman, MD | MD & Vice Chairman
1 company
Eric Cantor is Vice Chairman, MD at MC. Eric Cantor's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $14.5M at current prices.
The MC filings lean toward selling, a net 34,387 shares.
Eric Cantor has 100 Form 4 filings on record from March 2017 to September 2026, all as Vice Chairman, MD at Moelis & (MC), 2017–2026.
The 460 reported transactions were 364 option or other derivative awards, 47 option exercises, 47 tax withholdings and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $2.2M.
The largest open-market sale was 16,530 shares of MC at an average $74.00 on February 19, 2025, about $1.2M. Twelve months later MC was down 19%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.